NCT03696212 · Interventional trial
Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma
Overall registry status Terminated
Phase 1 · Phase 2
Conditions Non-small Cell Lung Cancer Adenocarcinoma
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
- University of Pennsylvania Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory